DestiNA Genomics

Hugh Ilyine, Destina Genomics

There is a feeling of support that comes not only from the British government providing this funding, but also from working with Leyton. Leyton’s work has been very rewarding for us, not just financially but also in terms of the motivation, headspace and management of the company

About the business

Founded in 2010, Destina Genomics is an early stage research and development company, based in Edinburgh, spun-out from research originating at the University of Edinburgh School of Chemistry. The company is developing transformative technology for the direct, PCR free detection of nucleic acid biomarkers, important in diagnosing for drug toxicities, cancer and disease.


DestiNA Genomics uses their unique, patented chemistry to accurately detect nucleic acid biomarkers in biological fluids such as blood serum and plasma, urine and saliva. With simpler protocols and high specificity, accurate direct quantification of short RNA biomarkers is now possible in biological fluids such as blood plasma and urine, a truly innovative advance over traditional tissue based pathology procedures.

How did the business benefit?

At this early stage where the business is dependent on grants and investor seed capital, every pound is really important for the company, and can make a huge difference to financing its research. DestiNA Genomics was aware of the scheme, but were unsure how much of their R&D effort would qualify, given that the company had established a subsidiary in Spain. After speaking to Leyton’s specialists, they discovered this research could also qualify for claim, the R&D being funded from the UK parent company. With the rebate, the business has been able to allocate funds in a more efficient way in terms of cash flow, as well as making better R&D project funding decisions.


By learning about their client needs, Leyton developed a ‘stress free’ process for the engagement, and an end results success. With a broad experience of working with other consultants, the client commented that Leyton had a contributory and balanced approach, with all the work prepared in a timely and friendly manner. Leyton was able to facilitate a quick turnaround during periods where the business faced time and project priority constraints.

Speak to our R&D Tax specialists

Contact us